Aptamer Microarrays-Current Status and Future Prospects

Research output: Contribution to journalArticleResearchpeer review

Authors

Research Organisations

View graph of relations

Details

Original languageEnglish
Pages (from-to)115-32
Number of pages18
Journalmicroarrays
Volume4
Issue number2
Publication statusPublished - 24 Mar 2015

Abstract

Microarray technologies are state of the art in biological research, which requires fast genome, proteome and transcriptome analysis technologies. Often antibodies are applied in protein microarrays as proteomic tools. Since the generation of antibodies against toxic targets or small molecules including organic compounds remains challenging the use of antibodies may be limited in this context. In contrast to this, aptamer microarrays provide alternative techniques to circumvent these limitations. In this article we review the latest developments in aptamer microarray technology. We discuss similarities and differences between DNA and aptamer microarrays and shed light on the post synthesis immobilization of aptamers including corresponding effects on the microarray performance. Finally, we highlight current limitations and future prospects of aptamer microarray technology.

Cite this

Aptamer Microarrays-Current Status and Future Prospects. / Witt, Martin; Walter, Johanna-Gabriela; Stahl, Frank.
In: microarrays, Vol. 4, No. 2, 24.03.2015, p. 115-32.

Research output: Contribution to journalArticleResearchpeer review

Witt M, Walter JG, Stahl F. Aptamer Microarrays-Current Status and Future Prospects. microarrays. 2015 Mar 24;4(2):115-32. doi: 10.3390/microarrays4020115
Witt, Martin ; Walter, Johanna-Gabriela ; Stahl, Frank. / Aptamer Microarrays-Current Status and Future Prospects. In: microarrays. 2015 ; Vol. 4, No. 2. pp. 115-32.
Download
@article{f8e6839c156640ac915365dfdc326b04,
title = "Aptamer Microarrays-Current Status and Future Prospects",
abstract = "Microarray technologies are state of the art in biological research, which requires fast genome, proteome and transcriptome analysis technologies. Often antibodies are applied in protein microarrays as proteomic tools. Since the generation of antibodies against toxic targets or small molecules including organic compounds remains challenging the use of antibodies may be limited in this context. In contrast to this, aptamer microarrays provide alternative techniques to circumvent these limitations. In this article we review the latest developments in aptamer microarray technology. We discuss similarities and differences between DNA and aptamer microarrays and shed light on the post synthesis immobilization of aptamers including corresponding effects on the microarray performance. Finally, we highlight current limitations and future prospects of aptamer microarray technology. ",
author = "Martin Witt and Johanna-Gabriela Walter and Frank Stahl",
year = "2015",
month = mar,
day = "24",
doi = "10.3390/microarrays4020115",
language = "English",
volume = "4",
pages = "115--32",
number = "2",

}

Download

TY - JOUR

T1 - Aptamer Microarrays-Current Status and Future Prospects

AU - Witt, Martin

AU - Walter, Johanna-Gabriela

AU - Stahl, Frank

PY - 2015/3/24

Y1 - 2015/3/24

N2 - Microarray technologies are state of the art in biological research, which requires fast genome, proteome and transcriptome analysis technologies. Often antibodies are applied in protein microarrays as proteomic tools. Since the generation of antibodies against toxic targets or small molecules including organic compounds remains challenging the use of antibodies may be limited in this context. In contrast to this, aptamer microarrays provide alternative techniques to circumvent these limitations. In this article we review the latest developments in aptamer microarray technology. We discuss similarities and differences between DNA and aptamer microarrays and shed light on the post synthesis immobilization of aptamers including corresponding effects on the microarray performance. Finally, we highlight current limitations and future prospects of aptamer microarray technology.

AB - Microarray technologies are state of the art in biological research, which requires fast genome, proteome and transcriptome analysis technologies. Often antibodies are applied in protein microarrays as proteomic tools. Since the generation of antibodies against toxic targets or small molecules including organic compounds remains challenging the use of antibodies may be limited in this context. In contrast to this, aptamer microarrays provide alternative techniques to circumvent these limitations. In this article we review the latest developments in aptamer microarray technology. We discuss similarities and differences between DNA and aptamer microarrays and shed light on the post synthesis immobilization of aptamers including corresponding effects on the microarray performance. Finally, we highlight current limitations and future prospects of aptamer microarray technology.

UR - http://www.repo.uni-hannover.de/handle/123456789/1581

U2 - 10.3390/microarrays4020115

DO - 10.3390/microarrays4020115

M3 - Article

C2 - 27600216

VL - 4

SP - 115

EP - 132

JO - microarrays

JF - microarrays

SN - 2076-3905

IS - 2

ER -

By the same author(s)